Traveler Brings Zika Virus Home to U.S.

Cases of the mosquito-borne infection are on the rise, with most reported in Brazil. The U.S. has confirmed at least two cases to date, including a recent importation into Texas.

Written byKaren Zusi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Aedes aegypti, a Zika virus vectorWIKIMEDIA, MUHAMMAD MAHDI KARIMUntil recently, Zika virus had been a little-known tropical disease. The mosquito-borne pathogen causes a low-grade fever, rash, and some mild aches and pains. According to the US Centers for Disease Control and Prevention (CDC), only one in five people infected will even develop symptoms. The World Health Organization (WHO) reported Zika on U.S. ground last week (January 8) in Puerto Rico, and Texas health officials confirmed a case this week (January 11); a resident who had traveled outside the country imported the virus upon returning to the states.

The CDC recently announced a possible link between Zika cases in Brazil and a spike in infant microcephaly, which causes children to be born with abnormally small heads. “I wouldn’t use [the term] smoking gun, but what I would say is that these data provide the strongest evidence to date of a possible link between Zika virus and microcephaly and other congenital abnormalities,” Lyle Petersen, the director of the CDC’s division of vector-borne diseases, told STAT News.

Brazil reported 147 cases of microcephaly in 2014, but as of this week (January 12), that number has risen to 3,530, the country’s Ministry of Health reported. The first potential links between Zika virus infection and microcephaly in Brazil were reported last November. Women who have been infected ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies